Matthew Henn

(Dr. Matthew Henn Ph.D.)

Currently holds a position at Seres Therapeutics Inc

Positions

Position Company Period
Chief Scientific Officer Seres Therapeutics Inc Feb. 7, 2019 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-19 2025-02-18
PS Planned sale
3,953 -4.5%
0.81
USD 3,204 		3,953 -4.5% 0.81 USD 3,204
2024-11-19 2024-11-18
PS Planned sale
927 -1.2%
0.54
USD 501 		927 -1.2% 0.54 USD 501
2024-10-29 2024-10-28
PS Planned sale
3,984 -5.0%
0.69
USD 2,749 		3,984 -5.0% 0.69 USD 2,749
2024-08-19 2024-08-16
PS Planned sale
923 -1.4%
0.84
USD 775 		923 -1.4% 0.84 USD 775
2024-05-17 2024-05-15
PS Planned sale
891 -1.3%
0.94
USD 838 		891 -1.3% 0.94 USD 838
2024-02-16 2024-02-16
PS Planned sale
4,170 -6.2%
1.08
USD 4,504 		4,170 -6.2% 1.08 USD 4,504
2023-10-31 2023-10-30
PS Planned sale
3,886 -6.5%
1.35
USD 5,246 		3,886 -6.5% 1.35 USD 5,246
2020-12-03 2020-12-01
PS Planned sale
9,841 -100.0%
28.34
USD 278,894 		9,841 -100.0% 28.34 USD 278,894
2020-12-03 2020-12-01
PS Planned sale
26,265 -72.7%
27.56
USD 723,863 		26,265 -72.7% 27.56 USD 723,863
2020-12-03 2020-12-01
PS Planned sale
55,706 -60.7%
26.56
USD 1,479,551 		55,706 -60.7% 26.56 USD 1,479,551
// ... existing code ... // ... rest of the file ...